NeuBase Therapeutics
Kayla Williams began their work experience as a Research Technician at the University of Pittsburgh in August 2021. Kayla worked in this role until February 2023. In February 2023, Kayla joined NeuBase Therapeutics, Inc. as an Associate Scientist, where they are currently employed.
Kayla Williams pursued their higher education at Penn State University from 2017 to 2021. During this time, they obtained a Bachelor's degree in Immunology and Infectious Disease.
This person is not in any offices
NeuBase Therapeutics
NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.